AZD8359 Clinical Trials (2026): 1 Studies for Metastatic Prostate Cancer
Hipa.ai Research · Source: ClinicalTrials.gov / AACT
Synced daily from ClinicalTrials.gov via AACT. Last sync: .
1 AZD8359 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 1 indication (including Metastatic Prostate Cancer) and 42 total planned enrollment. 1 AZD8359 clinical trial is actively recruiting at 1 U.S. site across 1 state. Most recent activity: NCT07529717 (Nov 2027).
Where to Participate: All AZD8359 Trial Sites in the U.S. (1 site across 1 state)
Every actively recruiting AZD8359trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
| State | Facility | City | Trial | Map |
|---|---|---|---|---|
| FL | Research Site | Orlando32806 | NCT07529717 | Map |
AZD8359 clinical trials at a glance: phase × recruitment status
| Phase | recruiting | Total |
|---|---|---|
| P1/P2 | 1 | 1 |
Recruiting AZD8359 clinical trials (1)
Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).
| NCT ID | Title | Phase | Indication | Enrollment | Started |
|---|---|---|---|---|---|
| NCT07529717 | CRIUS-1First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer | P1/P2 | Metastatic Prostate Cancer | 42 | May 2026 |
All AZD8359 trials (1)
Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.
| NCT ID | Acronym | Title | Phase | Status | Enrollment | Sponsor | Started |
|---|---|---|---|---|---|---|---|
| NCT07529717 | CRIUS-1 | First-in-Human Study to Evaluate AZD8359 STEAP2 TCE in Participants With Prostate Cancer | P1/P2 | recruiting | 42 | AstraZeneca | May 2026 |
AZD8359 clinical trials: frequently asked questions
- How many AZD8359 clinical trials are there?
- 1 AZD8359 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants.
- Are AZD8359 clinical trials recruiting in 2026?
- Yes — 1 AZD8359 trial is actively recruiting in 2026, with 1 U.S. site across 1 state. See the recruiting trials and the per-state site list further down this page.
- What conditions is AZD8359 being studied for?
- AZD8359 is being studied for Metastatic Prostate Cancer. The trials are grouped by indication on this page.
- Who sponsors AZD8359 clinical trials?
- The lead sponsor across the most AZD8359 trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AZD8359as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.
Last refreshed .
Related pages on Hipa.ai: